论文部分内容阅读
本文报道应用美国Cenfocor公司的抗CA19-9抗元的单抗固相放免分析试剂盒测试23例正常人,68例治疗前的各种良恶性消化道疾患,56例治疗后的胰腺癌,结肠癌患者血清中的CA19-9含量,同时检测了血清中CEA的含量。其结果是:正常人CA19-9
This article reports the use of the United States Cenfocor anti-CA19-9 monoclonal antibody solid-phase radioimmunoassay kit to test 23 cases of normal people, 68 cases of various benign and malignant gastrointestinal diseases before treatment, 56 cases of pancreatic cancer after treatment, colon The serum levels of CA19-9 were detected in patients with cancer and CEA levels were measured in serum. The result is: normal human CA19-9